Evidence map›Paper›PMID 35882684›Full record

ArticleBrain informatics2022

A robust framework to investigate the reliability and stability of explainable artificial intelligence markers of Mild Cognitive Impairment and Alzheimer's Disease.

Angela Lombardi, Domenico Diacono, Nicola Amoroso, Przemysław Biecek, Alfonso Monaco, Loredana Bellantuono, Ester Pantaleo, Giancarlo Logroscino, Roberto De Blasi, Sabina Tangaro and 1 more

Abstract read
In one paragraph

Article in Brain informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Angela LombardiDipartimento di Fisica, Università degli Studi di Bari Aldo Moro, Bari, Italy.
Domenico DiaconoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, Bari, Italy.
Nicola AmorosoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, Bari, Italy. nicola.amoroso@uniba.it.
Przemysław BiecekFaculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.
Alfonso MonacoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, Bari, Italy.
Loredana BellantuonoIstituto Nazionale di Fisica Nucleare, Sezione di Bari, Bari, Italy.
Ester PantaleoDipartimento di Fisica, Università degli Studi di Bari Aldo Moro, Bari, Italy.
Giancarlo LogroscinoDipartimento di Scienze mediche di base, Neuroscienze e Organi di senso, Università degli Studi di Bari Aldo Moro, Bari, Italy.
Roberto De BlasiPia Fondazione "Card. G. Panico", Tricase, Italy.
Sabina TangaroIstituto Nazionale di Fisica Nucleare, Sezione di Bari, Bari, Italy.
Roberto BellottiDipartimento di Fisica, Università degli Studi di Bari Aldo Moro, Bari, Italy.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904Research for Innovation - REFIN funded by Regione Puglia (Italy) in the framework of the POR Puglia FESR FSE 2014-2020 - Asse X - Azione 10.4. project code 928A7C98
6 · The paper itself

Abstract

In clinical practice, several standardized neuropsychological tests have been designed to assess and monitor the neurocognitive status of patients with neurodegenerative diseases such as Alzheimer's disease. Important research efforts have been devoted so far to the development of multivariate machine learning models that combine the different test indexes to predict the diagnosis and prognosis of cognitive decline with remarkable results. However, less attention has been devoted to the explainability of these models. In this work, we present a robust framework to (i) perform a threefold classification between healthy control subjects, individuals with cognitive impairment, and subjects with dementia using different cognitive indexes and (ii) analyze the variability of the explainability SHAP values associated with the decisions taken by the predictive models. We demonstrate that the SHAP values can accurately characterize how each index affects a patient's cognitive status. Furthermore, we show that a longitudinal analysis of SHAP values can provide effective information on Alzheimer's disease progression.

Indexed as

Alzheimer’s diseaseCognitive spectrumExplainable Artificial IntelligenceMild Cognitive ImpairmentXAI

Identifiers

PMID35882684
PMCPMC9325942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.